Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Saliva Collection Methods Evaluated for Proteome Analysis

By LabMedica International staff writers
Posted on 29 Apr 2013
The suitability of three different whole-saliva collection approaches for subsequent proteome analyses has been compared.

The saliva was obtained by passive drooling, cotton swabs and paraffin gums allowing similar coverage of the whole saliva proteome, but the specific proteins observed depended on the collection approach.

Scientists at the University Medicine Greifswald (Germany) collected saliva from nine healthy volunteers, four women and five men, whose mean age was 28 years. More...
Subjects had to be free of fever, without a cold, and maintained good oral hygiene. Immediately, after saliva collection, a Proteinase Inhibitor Cocktail (Sigma Aldrich; St. Louis, MO, USA) was added and saliva collection by the three methods was performed on three consecutive days.

Stimulated Salivette Saliva was collected by Salivette with cotton swabs (Sarstedt; Nümbrecht, Germany). For the stimulated paraffin gum study, volunteers were asked to chew for one minute using commercially available paraffin gum (Ivoclar Vivadent; Schaan, Lichtenstein). Afterwards the fluid was collected in a 15 mL falcon tube. A 50 mL falcon tube was also used to collect for one minute the passive unstimulated drooled saliva from the volunteers. The protein lysates from the saliva samples were analyzed by shotgun liquid chromatography–mass spectrometry. The amount and concentration of the protein as well as protein profiling data of whole saliva were comparatively analyzed.

Samples collected using paraffin gum showed the highest saliva volume at 4.1 ± 1.5 mL, followed by Salivette collection at 1.8 ± 0.4 mL and drooling at 1.0 ± 0.4 mL. Saliva protein concentrations with a mean of 1,145 μg/mL showed no significant differences between the three sampling schemes. Each collection approach facilitated the identification of about 160 proteins with more than two distinct peptides per subject, but collection-method dependent variations in protein composition were observed.

The authors concluded that the three collection methods allows similar coverage of the whole saliva proteome, but the specific proteins observed depended on the collection approach. Therefore, only one type of collection device should be used for quantitative proteome analysis, especially when performing large-scale cross-sectional or multicentric studies. The study was published on April 18, 2013, in the journal Clinica Chimica Acta.

Related Links:

University Medicine Greifswald
Sigma Aldrich
Sarstedt



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.